Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Acq. announced
Quarterly results
Auditor change
Appointed director
CC transcript
Director departure
|
|
SEELOS THERAPEUTICS, INC. (APRI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 4.7% stake in Seelos Therapeutics Inc. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 5% stake in Seelos Therapeutics Inc. |
| 01/15/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/11/2021 |
SC 13G/A
| Phoenixus AG reports a 0% stake in Seelos Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in Seelos Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13G/A
| CVI Investments, Inc. reports a 1.8% stake in Seelos Therapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| Iroquois Capital Management, LLC reports a 2.7% stake in Seelos Therapeutics, Inc. |
| 01/04/2019 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 3.2% stake in Apricus Biosciences, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 5.6% stake in Apricus Biosciences, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2017 |
SC 13G/A
| APRICUS BIOSCIENCES, INC. reports a 1.1% stake in APRICUS BIOSCIENCES, INC. |
| 02/06/2017 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 0.4% stake in Apricus Biosciences, Inc. |
| 02/14/2011 |
SC 13G/A
| APRICUS BIOSCIENCES, INC. reports a 2.9% stake in Apricus Biosciences, Inc. |
|
|